Synthetic data only. Never enter patient information; nothing is sent or stored. For clinicians. Not FDA cleared.For licensed clinicians. Educational demonstration on synthetic data. Never enter real patient identifiers or protected health information: everything runs in your browser and nothing is sent or stored. Clinical decision support only; not FDA cleared; physician review is required.
CPE-002 · Cross-engine triggers
CROSS-MASLD-002: FIB-4 Routing
FIB-4 Routing. Fires when liver_risk_review_indicated AND fib4_index at or above 1.3.
Active rulePriority 7Metabolic engine v1.0.0
Condition
- liver_risk_review_indicated AND fib4_index >= 1.3
Output
- SECONDARY_FIBROSIS_RISK_ASSESSMENT_CONSIDERATION
Diagnostic boundary
- Interpret within hepatic pathway only.
Evidence
- EV-AASLD-MASLDAmerican Association for the Study of Liver Diseases. Noninvasive Assessment of Patients with MASLD.Supports: FIB-4 <1.3 is generally used as an initial low-risk result in appropriate populations. FIB-4 >=1.3 prompts consideration of secondary assessment within a hepatic pathway.
Cases where this rule fires
Open a case to see this rule fire with real inputs, then change the values until it stops.
Try Biod in your practice
The Clinical Intelligence Layer — transforming fragmented clinical information into structured intelligence for clinician review and action.